Other fusion mutations observed in children with myeloproliferative disorders with the use of next-generation sequencing technologies include ALK, ROS1, FIP1L1::RARA, HCMOGT1::PDGFRB, NDEL1::PDGFRB, and NUP98::HOXA11. Here, PDGFRB is linked to myeloproliferative disorder.